The Effect of Omega 3 on 25 Hydroxyvitamin D (n-3FAon25OHD)

A

Applied Science Private University

Status

Completed

Conditions

25-hydroxyvitamin D Levels

Treatments

Dietary Supplement: Dietary Supplement: Omega3-FA

Study type

Interventional

Funder types

Other

Identifiers

NCT04174625
DRGS-2014-2015-165-5

Details and patient eligibility

About

The effect of omega 3 fatty acid on serum 25-hydroxyvitamin D levels.

Full description

No data are available on the effect of omega 3 on serum 25-hydroxyvitamin D levels in Jordanian men and women. This study was designed to investigate whether omega 3 supplementation has a potential effect on the reducing of serum 25-hydroxyvitamin D levels. This randomized, placebo-controlled clinical trial (RCT) was designed to evaluate 300 mg omega-3FA daily for 2 months on serum levels of 25-hydroxyvitamin D levels. This RCT will be conducted on 80 to 90 Jordanian men and women aged 22 to 66 years. Baseline and follow-up levels for 25-hydroxyvitamin D (25OHD), parathyroid hormone (PTH), calcium, phosphate, liver and kidney functions will be assayed.

Enrollment

80 patients

Sex

All

Ages

22 to 66 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age ≥18 years old

Male and female Jordanian ASU students and employees who live in Amman.

Informed written consent from the participant prior to the start of the study.

a serum 25(OH)D concentration between 10 and 70 ng/mL.

Exclusion criteria

Any eligiable subject refuses to apply with informed written consent before the start of the study.

Men or women previously diagnosed with chronic diseases, including kidney disease or GIT problems.

Who are receiving vitamin D3 supplements (3 months before the start of the study) .

Pregnants,Breastfeeding females ,Females using hormonal contraceptives

Trial design

80 participants in 2 patient groups

Omega3-FA group
Experimental group
Description:
Omega3-FA group 1000 mg wild salmon and fish oil complex (contains 300 mg of omega3-FA) once daily
Treatment:
Dietary Supplement: Dietary Supplement: Omega3-FA
Control group
Experimental group
Description:
VD3 group 50,000 IU/week
Treatment:
Dietary Supplement: Dietary Supplement: Omega3-FA

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems